Megestrol azetatoaren hautsari buruzko guztia

 

  1.Megestrol azetatazko berrikuspenak (CAS: 595-33-5)
  2. Nola egiten du Megestrol azetatoak?
  3. Nola egiten da megestrol aketatoaren hautsa?
  4. Zein neurri bereziak hartu behar dituzu megestrol aketatoaren hautsa hartu baino lehen?
  5. Nola hartu behar dut megestrol azetatoa hautsa?
  6. Erabili Megestrol azetatoa Powder populazio zehatzetan
  7. Zer jakin behar dut biltegiratze eta botika honen eskura?
  8.Megestrol aketatoaren bigarren mailako efektuak
  9.Megestrol azetatoaren pisua gain erabiltzeko arretaz kontuan hartu behar da
  10. Zein da Megestrol Acetate hautsari buruz jakin behar dudan informazio garrantzitsuena?
  11. Non lor dezaket Megestrol Azetatari buruzko informazio gehiago?

 


 

Megestrol azetatoa hauts bideoa

 

 


I. Mestestrol azetatoa hautsa oinarrizko karaktereak:

 

Izena: Megestrol azetatoa hautsa
CAS: 595 33--5
Formula molekularra: C19H26O3
Pisu molekularra: 302.41
Urteko puntua: -244 246 º C
Biltegiratze tenporala: Gela tenperatura
Kolorea: Hauts White

 


00

1. Megestrol azetatoakritikak (CAS:595 33--5)aasraw

 

Megestrol aketatoaren hautsa hormonaren tratamendu mota da. Megace edo megestrol deritzo ere (595 33--5). Hormona progesterona bertsioan egindako gizona da. Progesterona emakumezko hormonetariko bat da, baina gizonezkoek ere kopuru txiki bat sortzen dute.
Megestrol-aketatoaren hautsa atzera edo zabaldu denetik hasitako ondorengo minbizia izateko tratamendua da.

♦ Bularreko minbizia
♦ sabeleko minbizia
Gosea gosearen tratamendua ere bada. Zure medikuak gomendatzen dio minbizia edo tratamendua galtzen baduzu. Medikuek ere minbizia edo tratamendua eragiten duten emakumeentzako tratamendu gisa erabil dezakete.

 


 

2. Nola Megestrol azetatoalan?aasraw

 

Megestrol azetatoak hormona terapia mota bat da. Hormonas gorputzeko guruinek sortutako substantzia kimikoak dira, odolean sartzen direnak eta ehunak beste ondorioak eragiten dituztenak. (Adibidez, testosteronetan hormona testosterona gizonezkoen ezaugarrien arduraduna da, esate baterako, ahotsa sakontzea eta gorputz ilea handitzea). Minbizia tratatzeko hormonoterapia erabiltzea horma-hazkuntzako behar diren hormona espezifikoentzako errezeptoreak zelulen tumore batzuen gainazalean daude. Hormona-terapiak lan egiten dute; hormona jakin baten ekoizpena gelditu, hormona-errezeptoreen blokeoa edo tumore-zelula ez erabiltzeko hormona aktibo kimikoki antzekoak ordezkatuz. Terapia hormonal mota desberdinak funtzioaren arabera sailkatzen dira eta horregatik gertatzen da hormona mota.
Megestrol azetato bat da progestin (hormona progesterona gizakiaren forma). Estrogenoen ziklo normalaren eragina duten propietateak ditu. Horrek estrogenoen tumore zelularretan zelula hazkundearen estimulazioa eragiten du. Umetokiko horman (endometrioa) betetako efektu zuzena ere pentsatu behar da.
Megestrol azetatoaren bigarren mailako efektua pisua izan da. Efektu horren mekanismo zehatza ez da argi eta garbi, baina efektuak gorputz-gantzaren hazkundea eragiten du. Alboko efektu hori aprobetxatuz, Megestrol azetatoa aztertu eta erabiltzen da gosea galtze larria (anorexia), muskulu-mina (kachexia) eta pisu galera minbizia eta hiesa lotzen dituena erabiltzeko.

Megestrol azetatoaren lana, Megestrol azetatoaren hautsa (595-33-5) tratamendu hormonal mota bat da eta hormonen progesterona bertsioan egindako gizona da.

 


 

3. Nola kudeatzen da megestrol azetatoa hautsa?aasraw

 

Erabili medikuntza hau (Megestrol azetato hautsa) zure medikuak agindu bezala. Irakurri duzun informazio guztia irakurri. Jarraitu argibide guztiak hurbiletik.
♦ Onura handiena lortzeko, ez galdu dosiak.
♦ Jarrai ezazu medikuntza hau (Megestrol acetatoaren hautsa) zure medikuak edo bestelako sendagileari kontatu dizun moduan, nahiz eta ondo sentitu.

Zer egin dezaket dosi bat falta bada?

♦ Bota ezazu dosia galduta, pentsatzen duzun bezain laster.
♦ Hurrengo dosiaren inguruko denbora hurbil badago, galdutako dosi aurreztu eta ohiko orduetara itzuliko zara.
♦ Ez hartu 2 dosi aldi berean edo dosi gehigarririk.

 


 

4. What special precautions Before taking megestrol acetate powder?aasraw

 

♦ tell your doctor and pharmacist if you are allergic to megestrol acetate powder, any other medications, or any of the inactive ingredients in megestrol acetate powder, suspension, or concentrated suspension. Ask your doctor or pharmacist for a list of the inactive ingredients.
♦ tell your doctor and pharmacist what prescription and nonprescription medications, vitamins, nutritional supplements, and herbal products you are taking or plan to take. Be sure to mention antibiotics and indinavir (Crixivan). Your doctor may need to adjust the doses of your medications or monitor you carefully for side effects.
♦ tell your doctor if you have or have ever had a blood clot anywhere in the body, a stroke, diabetes, or kidney or liver disease.
♦ tell your doctor if you are pregnant, plan to become pregnant, or are breast-feeding. If you become pregnant while taking megestrol acetate powder, call your doctor immediately. megestrol acetate powder may harm the fetus. Do not breast-feed while you are taking megestrol acetate powder.
♦ you should know that megestrol acetate powder may interfere with the normal menstrual cycle (period) in women. However, you should not assume that you cannot become pregnant. Use a reliable method of birth control to prevent pregnancy.
♦ if you are having surgery, including dental surgery, during or shortly after your treatment, tell the doctor or dentist that you are taking megestrol acetate powder.


 

5. Nola hartu behar dut megestrol azetatoa hautsa?aasraw

Hartu zehazki zure medikuak agindutakoa. Ez hartu neurri handiago edo txikiagoetan edo gomendatzen baino luzeagoa. Jarraitu zure errezetarik gabeko etiketaren jarraibideak.
Shake the oral suspension (liquid) well just before you measure a dose. Measure the liquid with a special dose-measuring spoon or medicine cup, not with a regular table spoon. If you do not have a dose-measuring device, ask your pharmacist for one.
Megace ES contains a higher concentration of megestrol acetate powder than Megace. If your doctor changes your brand, strength, or type of megestrol acetate powder, your dosage needs may change. Ask your pharmacist if you have any questions about the medicine you receive at the pharmacy.
Your dosage needs may change if you have surgery, are ill, are under stress, or have an infection. Do not change your medication dose or schedule without your doctor’s advice. Store at room temperature away from moisture and heat.

 


 

6. Erabili Megestrol azetatoa Powder in specific populationsaasraw

 

 Haurdunaldia

Pregnancy Category X [see Warnings and Precautions (5.2)]. No adequate animal teratology information is available at clinically relevant doses. Pregnant rats treated with low doses of Megestrol acetate powder (0.02-fold the recommended clinical dose) resulted in a reduction in fetal weight and number of live births, and feminization of male fetuses.

 Erizaintzako amak

Because of the potential for adverse effects on the newborn, nursing should be discontinued if Megestrol acetate powder is required.

 Pediatric Use

Safety and effectiveness in pediatric patients have not been established.

 Geriatric Use

Clinical studies of Megestrol acetate powder in the treatment of anorexia, cachexia, or an unexplained significant weight loss in patients with AIDS did not include sufficient numbers of patients aged 65 years and older to determine whether they respond differently than younger patients. Other reported clinical experience has not identified differences in responses between elderly and younger patients. In general, dose selection for an elderly patient should be cautious, usually starting at the low end of the dosing range, reflecting the greater frequency of decreased hepatic, renal, or cardiac function, and of concomitant disease or other drug therapy.
Megestrol acetate powder  is known to be substantially excreted by the kidney, and the risk of toxic reactions to this drug may be greater in patients with impaired renal function. Because elderly patients are more likely to have decreased renal function, care should be taken in dose selection, and it may be useful to monitor renal function.

 Use in Women

Megestrol acetate powder has had limited use in HIV infected women. All 10 women in the clinical trials reported breakthrough bleeding. Megestrol acetate powder is a progesterone derivative, which may induce vaginal bleeding in women.

The most comprehensive introduction for Megestrol acetate powder | AASraw

 


 

7. Zer jakin behar dut biltegiratze eta botika honen eskura?aasraw

 

Jarrai ezazu medikazio hau edukiontzi batean, ondo itxi eta seme-alaben eskura. Gorde tenperaturan eta gehiegizko beroa eta hezetasuna (ez bainugelan).
Garrantzitsua da haurraren botika guztiak ikustea eta haurraren eskura edukitzea (adibidez, pilula pilula astunak eta begi tanta, kremak, adabakiak eta inhalatzaileak) ez diren haurrentzako erresistentea eta haur txikiek erraz ireki ditzakete. Intoxikazioak haurrak babesteko, segurtasun txanoak blokeatu eta berehalako kokapenean sendagaiak jartzea - ​​bat gora eta behera eta ikusmena eta eskura.
Unneeded medications should be disposed of in special ways to ensure that pets, children, and other people cannot consume them. However, you should not flush this medication down the toilet. Instead, the best way to dispose of your medication is through a medicine take-back program. Talk to your pharmacist or contact your local garbage/recycling department to learn about take-back programs in your community. find www.aasraw.com for more information if you do not have access to a take-back program.

 


 

8. Megestrol acetateBigarren mailako efektuakaasraw

 

Megace (megestrol acetate, USP) Oral Suspension is a man-made chemical similar to the female hormone progesterone used to treat loss of appetite and weight loss because of disease, and is also used in the treatment of advanced breast cancer and endometrial cancer. Megace is available in generic form. Common side effects of Megace include:
· weight gain
· Gosea aldatzea
· stomach upset
· Beherakoa
· gas
· Azalaren larruazala
· trouble sleeping (insomnia)
· weakness
· decreased sexual ability/desire
· impotence
· trouble having an orgasm
Sukarra
Women may experience changes in menstrual periods, including unpredictable vaginal bleeding.The recommended adult initial dosage of Megace Oral Suspension is 800 mg/day (20 mL/day). Megace may interact with insulin or oral diabetes medicine and may decrease the effects of these medications, and blood sugar levels may increase. If you have diabetes, monitor blood sugar and talk to your doctor if you notice unusual changes. Megace may interact with indinavir, or insulin or oral diabetes medications. Tell your doctor all medications and supplements you use. Megace must not be used during pregnancy. It may cause harm to a fetus. Women of childbearing age should use birth control while using this medication. This medication may pass into breast milk and could have undesirable effects on a nursing infant. Breast-feeding is not recommended while using this drug.
Our Megace (megestrol acetate, USP) Side Effects Drug Center provides a comprehensive view of available drug information on the potential side effects when taking this medication.
Hau ez da bigarren mailako efektuen zerrenda osoa eta beste batzuk gerta daitezke. Deitu medikuari bigarren mailako efektuei buruzko aholkularitza medikoa. Bigarren mailako efektuak FDArekin jakinarazi ditzakezu 1-800-FDA-1088-n.

 


 

9. Megestrol Acetate Use for Weight Gain Should Be Carefully Consideredaasraw

 

The most comprehensive introduction for Megestrol acetate powder | AASraw

The most comprehensive introduction for Megestrol acetate powder | AASraw

Megestrol acetate (595 33--5) is a progestational agent with a powerful effect on appetite. It was initially used as a contraceptive agent; however, the common side effect of weight gain led to its current use as an orexigenic agent. Administration of MA results in substantial increases in appetite and body weight in patients with HIV-associated wasting and in those with cancer. MA is currently Food and Drug Administration (FDA) approved for HIV-associated weight loss. In addition, both in healthy, community-dwelling older individuals and elderly people residing in long-term care facilities, the use of MA results in a robust increase in body weight. The use of orexigenic agents such as MA in these settings is appropriate because involuntary weight loss has been associated with increased mortality. Indeed, MA has a greater effect on body weight and appetite than other orexigenic agents such as dronabinol and eicospentaenoic acid. However, in older people and patients with cancer or renal failure, fat is the principal or the only constituent of weight gain, with little accrual of skeletal muscle or other components of fat-free mass. Among the many side effects of the use of MA, suppression of testosterone and estrogen production is prominent. Before the common use of other effective androgen suppressive treatments (flutamide, bicalutamide) in men with prostate cancer, MA was commonly used in this setting. Indeed, in older men, use of MA results in near-castrate levels of testosterone. MA has also been used to suppress estrogen levels in women with breast cancer.
The study published this month in JCEM examined the combined effects of testosterone and MA on the composition of weight gain in patients with HIV-associated wasting. This study demonstrates, once again, that MA has a substantial effect on appetite and body weight, with fat gain the principal component of the increase in body weight. However, fat-free mass was also increased along with total body weight in this trial, similar to a previous examination of the effect of MA on weight gain in patients with HIV-associated weight loss. Mulligan et al.showed that testosterone was suppressed, and testosterone replacement had no effect on the composition of the weight gain; furthermore, MA administration resulted in decreased libido. This suppressive effect of MA on testosterone production and in blocking the effects of testosterone on lean body mass accrual should be carefully considered before using MA in this patient population. Loss of lean mass in HIV patients is strongly linked to low androgen levels.
A number of unanswered questions concerning the effects of MA remain. Its use must be carefully considered and carefully managed. If an improvement in appetite and a gain in fat mass are desirable goals in the management of cachexia or involuntary weight loss, MA remains one of the most potent orexigenic agents currently available. Its use must be weighed against the potential for adrenal suppression and suppression of androgen production. Because of its antiandrogen properties, the antianabolic effects of MA are not ameliorated by testosterone administration.

 


 

10. What is the most important information I should know about Megestrol Acetatehauts?aasraw

 

Megestrol acetate powder can harm an unborn baby or cause birth defects. Do not use megestrol if you are pregnant.
Before you take megestrol acetate powder, tell your doctor if you have diabetes or a history of stroke or blood clot.
Zure dosia beharrak aldatu egin daitezke kirurgia badaukazu, gaixo daude, estresa edo infekzioa izaten dute. Ez aldatu zure botikak dosi edo ordutegia zure medikuaren aholkuarekin.
Megace ES contains a higher concentration of megestrol acetate powder than Megace. Ask your pharmacist if you have any questions about the medicine you receive at the pharmacy.

The most comprehensive introduction for Megestrol acetate powder | AASraw

 


 

11. Where can I get more information on Megestrol Acetate?aasraw

 

♣ CAS: 595-33-5
♣ Brand name: Megace®, Megace® ES
♣ www.aasraw.com

 


 

1 Atsegin |
83 Views

Iruzkina A

Mesedez, sartu zure izena. Sartu baliozko helbide elektroniko bat. Mesedez sartu mezua.

Captcha *